EpiCept Corporation (EPCT) Reports Q2 EPS Loss of $0.06
Tweet
Share
E-mailGet Alerts EPCT Hot Sheet
Price: $0.08 --0%
Financial Fact:
Loss from operations: -3.98M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: -3.98M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
EpiCept Corporation (NASDAQ: EPCT) reported Q2 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $224 thousand versus the consensus estimate of $270 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
